These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 2589483
21. Increased expression of CD54, CD18, MHC class II molecules, and proliferating cell nuclear antigen in acute puromycin aminonucleoside nephrosis. Fernandez L, Romero M, Rincón J, Mosquera J. Nephron Exp Nephrol; 2003; 94(2):e55-65. PubMed ID: 12845231 [Abstract] [Full Text] [Related]
22. The antiinflammatory effects of essential fatty acid deficiency in experimental glomerulonephritis. The modulation of macrophage migration and eicosanoid metabolism. Schreiner GF, Rovin B, Lefkowith JB. J Immunol; 1989 Nov 15; 143(10):3192-9. PubMed ID: 2809195 [Abstract] [Full Text] [Related]
23. Effect of a low-protein diet on expression of non-muscle type myosin heavy-chain isoforms in glomeruli of rats with puromycin aminonucleoside nephrosis. Koide H, Nakamura T, Kimura K, Ebihara I, Nagai R, Tomino Y. Nephrol Dial Transplant; 1996 Sep 15; 11(9):1769-74. PubMed ID: 8918620 [Abstract] [Full Text] [Related]
27. Glomerular epithelial detachment, not reduced charge density, correlates with proteinuria in adriamycin and puromycin nephrosis. Whiteside C, Prutis K, Cameron R, Thompson J. Lab Invest; 1989 Dec 15; 61(6):650-60. PubMed ID: 2601299 [Abstract] [Full Text] [Related]
28. Studies on the mechanism of the onset of proteinuria in aminonucleoside nephrosis. Gang NF, Mautner W. Lab Invest; 1972 Sep 15; 27(3):310-6. PubMed ID: 4626934 [No Abstract] [Full Text] [Related]
29. Protective effect of radical scavenger edaravone against puromycin nephrosis. Matsumura H, Ashida A, Hirano K, Nakakura H, Tamai H. Clin Nephrol; 2006 Dec 15; 66(6):405-10. PubMed ID: 17176911 [Abstract] [Full Text] [Related]
30. Increased apoptosis in acute puromycin aminonucleoside nephrosis. Fernandez L, Romero M, Soto H, Mosquera J. Exp Nephrol; 2001 Dec 15; 9(2):99-108. PubMed ID: 11150858 [Abstract] [Full Text] [Related]
31. Involvement of thromboxane A2, leukotrienes and free radicals in puromycin nephrosis in rats. Shibouta Y, Terashita Z, Imura Y, Shino A, Kawamura M, Ohtsuki K, Ohkawa S, Nishikawa K, Fujiwara Y. Kidney Int; 1991 May 15; 39(5):920-9. PubMed ID: 2067208 [Abstract] [Full Text] [Related]
33. Macrophages mediate adverse effects of cholesterol feeding in experimental nephrosis. Pesek-Diamond I, Ding G, Frye J, Diamond JR. Am J Physiol; 1992 Nov 15; 263(5 Pt 2):F776-83. PubMed ID: 1443168 [Abstract] [Full Text] [Related]
34. Inhibition of progression of chronic puromycin aminonucleoside nephrosis by probucol, an antioxidant. Magil A. J Am Soc Nephrol; 1996 Nov 15; 7(11):2340-7. PubMed ID: 8959623 [Abstract] [Full Text] [Related]
35. Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol. Ricardo SD, Bertram JF, Ryan GB. Exp Nephrol; 1995 Nov 15; 3(5):270-9. PubMed ID: 7583048 [Abstract] [Full Text] [Related]
39. Lovastatin reduces glomerular macrophage influx and expression of monocyte chemoattractant protein-1 mRNA in nephrotic rats. Park YS, Guijarro C, Kim Y, Massy ZA, Kasiske BL, Keane WF, O'Donnell MP. Am J Kidney Dis; 1998 Jan 15; 31(1):190-4. PubMed ID: 9428473 [Abstract] [Full Text] [Related]
40. Stable analogs of prostaglandins E1 and F2 alpha ameliorate the proteinuria of aminonucleoside-of-puromycin nephrosis in Lewis rats. Ulich TR, Meline JA, Ni RX, Keys M, Wu CH. Am J Pathol; 1987 Oct 15; 129(1):133-9. PubMed ID: 3499082 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]